What Would Help or Hinder Patient Participation in Clinical Trials for Mitochondrial Disease?

As clinical trials gear up with the aim of attaining the first FDA-approved treatments for mitochondrial disease, a new study reports for the first time what patients and families say would motivate them for or against participating in such research trials.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News